Table 1.
Parameter | Group | Initial | Final | Time | Group | Time vs. group |
---|---|---|---|---|---|---|
Total volume infused | Saline | — | 4.3 ± 1.6 | – | – | – |
(mL) | 5% ALB | 2.7 ± 0.6* | ||||
20% ALB | — | 2.6 ± 0.5* | ||||
Albumin infused | Saline | — | – | |||
(g/kg) | 5% ALB | — | 0.42 ± 0.22 | |||
20% ALB | — | 1.42 ± 0.56† | – | – | – | |
Hematocrit | Saline | 0.38 ± 0.06. | 0.38 ± 0.03 | |||
(SI) | 5% ALB | 0.38 ± 0.05 | 0.34 ± 0.07 | p = 0.10 | p = 0.64 | p = 0.18 |
20% ALB | 0.39 ± 0.03 | 0.38 ± 0.06 | ||||
MAP | Saline | 72 ± 21 | 104 ± 17‡ | |||
(mmHg) | 5% ALB | 78 ± 35 | 100 ± 20‡ | p < 0.01 | p = 0.78 | p = 0.82 |
20% ALB | 77 ± 25 | 112 ± 36‡ | ||||
HR | Saline | 318 ± 66 | 325 ± 66 | |||
(bpm) | 5% ALB | 337 ± 91 | 351 ± 59 | p = 0.70 | p = 0.32 | p = 0.46 |
20% ALB | 324 ± 71 | 280 ± 82 | ||||
dIVC | Saline | 0.56 [0.42–0.83] | 0.22 [0.14–0.29]‡ | |||
(SI) | 5% ALB | 0.39 [0.33–0.84] | 0.16 [0.09–0.25]‡ | p < 0.001 | p = 0.71 | p = 0.99 |
20% ALB | 0.42 [0.34–0.90] | 0.20 [0.05–0.25]‡ | ||||
SV | Saline | 0.26 ± 0.12 | 0.33 ± 0.12‡ | |||
(mL) | 5% ALB | 0.36 ± 0.14 | 0.42 ± 0.08‡ | p = 0.01 | p = 0.20 | p = 0.19 |
20% ALB | 0.27 ± 0.05 | 0.54 ± 0.26‡ | ||||
CO | Saline | 87 ± 53 | 97 ± 77 | |||
(mL/min) | 5% ALB | 124 ± 40 | 132 ± 53 | p = 0.20 | p = 0.35 | p = 0.59 |
20% ALB | 93 ± 26 | 140 ± 104‡ |
Data are shown as mean ± SD; 20% ALB, 20% albumin; 5% ALB, 5% albumin. Comparisons among groups at each time point (INITIAL and FINAL) were done by two-way ANOVA followed by Holm–Šídák's multiple comparisons. For comparison of total volume infused, the Kruskal–Wallis test with Dunn's multiple comparisons was used. For comparison of albumin volume infused, the Mann–Whitney U-test was used. MAP, mean arterial pressure; HR, heart rate; dIVC, distensibility index of the inferior vena cava; SV, stroke volume; CO, cardiac output; SI, International System of Units.
vs Saline (p < 0.05);
vs 5% ALB (p < 0.01);
vs Initial (p < 0.05).